New insights into lipid metabolism in the nephrotic syndrome

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Kaysen, George A ^a   De Sain Van Der Velden, Monique G M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

ApoB 100; Catabolism; Fibrinogen; HDL; LDL; Lipase; Lipoprotein synthesis; Lp(a); VLDL

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

CONFERENCE PAPER; ENZYME BINDING; ENZYME SYNTHESIS; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN SYNTHESIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REGULATORY MECHANISM; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VASCULAR ENDOTHELIUM; ANIMAL; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; HUMANS; LIPID METABOLISM; LIPOPROTEINS; NEPHROTIC SYNDROME;

EID: 0032974220     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. DE SAIN-VAN DER VELDEN MG, KAYSEN GA, BARRETT HA, STELLAARD F, GADELLAA MM, VOORBIJ HA, REIJNGOUD DJ, RABELINK TJ: Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int 53:994-1001, 1998
2. WANNER C, RADER D, BARTENS W, KRAMER J, BREWER HB, SCHOLLMEYER P, WIELAND H: Elevated plasma lipoprotein (a) in patients with the nephrotic syndrome. Ann Int Med 119:263-269, 1993
3. LEVY E, ZIV E, BAR-ON H, SHAFRIR E: Experimental nephrotic syndrome: Removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin. Biochim Biophys Acta 1043:259-266, 1990
4. DAVIES RW, STAPRANS I, HUTCHISON FN, KAYSEN GA: Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 86:600-605, 1990
5. MURDOCH SJ, BRECKENRIDGE WC: Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Atherosclerosis 118:193-212, 1995
6. KASHYAP ML, SRIVASTAVA LS, HYND BA, BRADY D, PERISUTTI F, GLUECK CJ, GARTSIDE PS: Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome. Atherosclerosis 35:29-40, 1980
7. KAYSEN GA, PAN XM, COUSER WG, STAPRANS I: Defective lipolysis persists in hearts of rats with Heymann nephritis in the absence of nephrotic plasma. Am J Kidney Dis 22:128-134, 1993
8. Deleted in proof.
9. SALINELLI S, Lo JY, MIMS MP, ZSIGMOND E, SMITH LC, CHAN L: Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center. J Biol Chem 271:21906-21913, 1996
10. GARBER DW, GOTTLIEB BA, MARSH JB, SPARKS CE: Catabolism of very low density lipoproteins in experimental nephrosis. J Clin Invest 74:1375-1383, 1984
11. LIANG K, VAZIRI ND: Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int 51:1761-1765, 1997
12. LIANG K, VAZIRI ND: Down-regulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int 51:1933-1937, 1997
13. SASAKI A, GOLDBERG IJ: Lipoprotein lipase release from BFC-1 beta adipocytes. Effects of triglyceride-rich lipoproteins and lipolysis products. J Biol Chem 267:15198-15204, 1992
14. EISENBERG S: High density lipoprotein metabolism. J Lip Res 25:1017-1058, 1984
15. SICH D, SAIDI Y, GIRAL P, LAGROST L, DALLONGEVILLE J, FEDERSPIEL MC, CHERFILS C, RAISONNIER A, TURPIN G, BEUCLER I: Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency. Atherosclerosis 138:351-360, 1998
16. TARUGI P, BALLARINI G, PINOTTI B, FRANCHINI A, OTTAVIANI E, CALANDRA S: Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney. J Lipid Res 39:7317-7343, 1998
17. KAYSEN GA: Nephrotic hyperlipidemia: Primary abnormalities in both lipoprotein catabolism and synthesis. Miner Electrolyte Metab 18:212-216, 1992
18. SUN X, MARTIN V, WEISS RH, KAYSEN GA: Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis. Am J Physiol 264:F441-F447, 1993
19. DE SAIN-VAN DER VELD EN MG, KAYSEN GA, DE MEER K, STELLAARD F, VOORBIJ HA, REIJNGOUD DJ, RABELINK TJ, KOOMANS HA: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes. Kidney Int 53:181-188, 1998
20. KAYSEN GA, SUN X, JONES H JR, MARTIN VI, JOLES JA, TSUKAMOTO H, COUSER WG, AL-BANDER H: Non-iron mediated alteration in hepatic transferrin gene expression in the nephrotic rat. Kidney Int 47:1068-1077, 1995
21. KAYSEN GA, JONES H JR, MARTIN V, HUTCHISON FN: A low protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 83:1623-1629, 1989
22. SUN X, JONES H JR, JOLES JA, VAN TOL A, KAYSEN GA: Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol 262:F755-F761, 1992
23. MARSH JB, DRABKIN DL: Experimental reconstruction of metabolic pattern of lipid nephrosis: Key role of hepatic protein synthesis in hyperlipemia. Metabolism 9:946, 1960
24. OOYEN C, ZECCA A, ZANELLI T, CATAPANO AL: Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesis. Atherosclerosis 130:143-152, 1997
25. GAVISH D, AZROLAN N, BRESLOW J: Plasma Lp (a) concentration is inversely correlated with the ratio of kringle IV/kringle V encoding domains in the apo (a) gene J. Clin Invest 84:2021-2027, 1989
26. DE SAIN-VAN DER VELDEN MGM, JAN REIJNGOUD D, KAYSEN GA, GADELLAA MM, VOORBIJ M, STELLAARD F, KOOMANS HA, RABELINK TJ: Evidence for increased synthesis of Lipoprotein (a) in the nephrotic syndrome. J Am Soc Nephrol 9:1474-1481, 1998
27. SECHI LA, KRONENBERG F, DE CARLI S, FALLETI E, ZINGARO L, CATENA C, UTERMANN G, BARTOLI E: Association of serum lipoprotein (a) levels and apolipoprotein (a) size polymorphism with target-organ damage in arterial hypertension. JAMA 277:1689-1695, 1997